• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾损伤与肠道菌群失调

Acute Kidney Injury and Intestinal Dysbiosis.

作者信息

Chávez-Iñiguez Jonathan Samuel, Villegas-Gutiérrez Luz Yareli, Gallardo-González Alejandro Martínez

机构信息

Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.

University Center for Health Sciences, University of Guadalajara, Guadalajara, Mexico.

出版信息

Front Nephrol. 2022 Jul 7;2:916151. doi: 10.3389/fneph.2022.916151. eCollection 2022.

DOI:10.3389/fneph.2022.916151
PMID:37675014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10479571/
Abstract

Within the multiple communication pathways of the intestine-kidney axis, one of the most important pathways is the interaction between the commensals of the intestinal microbiome, through the production of short-chain fatty acids, and the segments of the nephron. These interactions maintain a perfect environmental balance. During AKI, there are negative repercussions in all organs, and the systemic interconnection is related in part to the intense inflammation and the uremic environment that this syndrome generates. For example, in the intestine, the microbiome is severely affected, with a decrease in benign bacteria that promote anti-inflammatory effects and an increase in negative, pro-inflammatory bacteria. This scenario of intestinal dysbiosis widens the inflammatory loop that favors worsening kidney function and the probability of dying. It is possible that the manipulation of the intestinal microbiome with probiotics, prebiotics and symbiotics is a reasonable therapeutic goal for AKI.

摘要

在肠-肾轴的多种通讯途径中,最重要的途径之一是肠道微生物群的共生菌通过产生短链脂肪酸与肾单位各节段之间的相互作用。这些相互作用维持着完美的环境平衡。在急性肾损伤期间,所有器官都会受到负面影响,全身的相互联系部分与该综合征引发的强烈炎症和尿毒症环境有关。例如,在肠道中,微生物群受到严重影响,促进抗炎作用的良性细菌减少,而具有负面促炎作用的细菌增加。这种肠道生态失调的情况会扩大炎症循环,进而导致肾功能恶化和死亡几率增加。用益生菌、益生元和合生元对肠道微生物群进行调控可能是急性肾损伤一个合理的治疗目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3326/10479571/82cb47406a5e/fneph-02-916151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3326/10479571/82cb47406a5e/fneph-02-916151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3326/10479571/82cb47406a5e/fneph-02-916151-g001.jpg

相似文献

1
Acute Kidney Injury and Intestinal Dysbiosis.急性肾损伤与肠道菌群失调
Front Nephrol. 2022 Jul 7;2:916151. doi: 10.3389/fneph.2022.916151. eCollection 2022.
2
Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.急性肾损伤与肠道菌群失调:一篇以病理生理学和治疗为重点的综述。
Int J Mol Sci. 2022 Mar 26;23(7):3658. doi: 10.3390/ijms23073658.
3
The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.肠道微生物群、高血压和肾脏疾病之间的相互作用:短链脂肪酸的作用。
Pharmacol Res. 2019 Mar;141:366-377. doi: 10.1016/j.phrs.2019.01.019. Epub 2019 Jan 10.
4
Microbiota and prebiotics modulation of uremic toxin generation.微生物群和益生元对尿毒症毒素生成的调节作用
Panminerva Med. 2017 Jun;59(2):173-187. doi: 10.23736/S0031-0808.16.03282-1. Epub 2016 Dec 21.
5
Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.急性肾损伤中的肠道微生物群失调:机制的新见解和有前景的治疗策略。
Ren Fail. 2022 Dec;44(1):571-580. doi: 10.1080/0886022X.2022.2056054.
6
Intestinal microbiota control acute kidney injury severity by immune modulation.肠道微生物群通过免疫调节控制急性肾损伤的严重程度。
Kidney Int. 2020 Oct;98(4):932-946. doi: 10.1016/j.kint.2020.04.048. Epub 2020 May 26.
7
Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.肠道微生物群-肾脏相互作用在急性肾损伤中的作用。
Semin Nephrol. 2019 Jan;39(1):107-116. doi: 10.1016/j.semnephrol.2018.10.009.
8
Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review.慢性肾脏病中益生菌/益生元对肠道微生物群的调节、氮产物的控制及炎症反应:一项系统评价
Nutr Hosp. 2018 Apr 27;35(3):722-730. doi: 10.20960/nh.1642.
9
Interactions of probiotics and prebiotics with the gut microbiota.益生菌和益生元与肠道微生物群的相互作用。
Prog Mol Biol Transl Sci. 2020;171:265-300. doi: 10.1016/bs.pmbts.2020.03.008. Epub 2020 Apr 24.
10
[Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].[慢性肾脏病肠道微生物群失调的发病机制、治疗及中药的干预作用]
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(13):2425-2432. doi: 10.19540/j.cnki.cjcmm.20170609.014.

引用本文的文献

1
Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets.急慢性疾病中的肝肾相互作用:从共同通路到治疗靶点
Biomedicines. 2025 Jul 1;13(7):1618. doi: 10.3390/biomedicines13071618.
2
Interplay between gut microbiota and acute kidney injury: a review of their mutual influence and causation.肠道微生物群与急性肾损伤之间的相互作用:对它们相互影响及因果关系的综述
Ren Fail. 2025 Dec;47(1):2522976. doi: 10.1080/0886022X.2025.2522976. Epub 2025 Jul 1.
3
Effect of probiotics on the incidence of acute kidney injury in patients with severe pneumonia.

本文引用的文献

1
Global Perspectives in Acute Kidney Injury: Mexico.急性肾损伤的全球视角:墨西哥
Kidney360. 2022 Jan 25;3(4):737-739. doi: 10.34067/KID.0006592021. eCollection 2022 Apr 28.
2
Urinary metabolites predict mortality or need for renal replacement therapy after combat injury.尿代谢物可预测战斗损伤后的死亡率或肾脏替代治疗需求。
Crit Care. 2021 Mar 23;25(1):119. doi: 10.1186/s13054-021-03544-2.
3
Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial.
益生菌对重症肺炎患者急性肾损伤发生率的影响。
Front Med (Lausanne). 2025 May 21;12:1596037. doi: 10.3389/fmed.2025.1596037. eCollection 2025.
4
Investigating gut microbiota-blood and urine metabolite correlations in early sepsis-induced acute kidney injury: insights from targeted KEGG analyses.探究早期脓毒症诱导的急性肾损伤中肠道微生物群-血液和尿液代谢物的相关性:来自靶向 KEGG 分析的见解。
Front Cell Infect Microbiol. 2024 Jun 3;14:1375874. doi: 10.3389/fcimb.2024.1375874. eCollection 2024.
5
The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study.特定肠道微生物群与膜性肾病风险的因果关联:一项孟德尔随机化研究。
Int Urol Nephrol. 2024 Jun;56(6):2021-2030. doi: 10.1007/s11255-023-03926-1. Epub 2024 Jan 5.
6
Probiotics in septic acute kidney injury, a double blind, randomized control trial.益生菌治疗脓毒症急性肾损伤的双盲随机对照试验。
Ren Fail. 2023;45(2):2260003. doi: 10.1080/0886022X.2023.2260003. Epub 2023 Sep 19.
缓释吡非尼酮对脓毒症急性肾损伤患者肾功能的影响:一项双盲安慰剂对照临床试验
Int J Nephrol. 2021 Jan 13;2021:8833278. doi: 10.1155/2021/8833278. eCollection 2021.
4
The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling-A Systematic Review.急性肾损伤中微生物群与尿毒症毒素之间的联系:超越直觉——一项系统综述
Toxins (Basel). 2020 Dec 11;12(12):788. doi: 10.3390/toxins12120788.
5
Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis.脓毒症相关性急性肾损伤的发生率、预测因素和死亡率:系统评价和荟萃分析。
BMC Nephrol. 2020 Jul 31;21(1):318. doi: 10.1186/s12882-020-01974-8.
6
Microbiome-Metabolome Signature of Acute Kidney Injury.急性肾损伤的微生物组-代谢组特征
Metabolites. 2020 Apr 4;10(4):142. doi: 10.3390/metabo10040142.
7
Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis.唾液乳杆菌 BP121 通过缓解肠道菌群失调来抑制尿毒症毒素(如吲哚硫酸酯和对甲酚硫酸酯),从而预防顺铂诱导的急性肾损伤。
Int J Mol Med. 2020 Apr;45(4):1130-1140. doi: 10.3892/ijmm.2020.4495. Epub 2020 Feb 10.
8
Correlation between the Incidence and Attributable Mortality Fraction of Acute Kidney Injury: A Systematic Review.急性肾损伤发病率与归因死亡率的相关性:系统评价。
Blood Purif. 2020;49(4):386-393. doi: 10.1159/000505568. Epub 2020 Jan 22.
9
Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.脓毒症导致的急性肾损伤:当前概念、流行病学、病理生理学、预防和治疗。
Kidney Int. 2019 Nov;96(5):1083-1099. doi: 10.1016/j.kint.2019.05.026. Epub 2019 Jun 7.
10
Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study.血清吲哚硫酸酯与医院获得性急性肾损伤的死亡率相关:一项前瞻性队列研究。
BMC Nephrol. 2019 Feb 14;20(1):57. doi: 10.1186/s12882-019-1238-9.